Literature DB >> 23908440

To be, or not to be, an eosinophil: that is the ???

Steven J Ackerman1.   

Abstract

In this issue of Blood, Doyle et al provide evidence that knockout of the genes encoding the two most abundant eosinophil secondary granule proteins disrupts the normal differentiation of eosinophils from progenitors in the bone marrow, providing a novel strain of mice with a highly specific deficiency in eosinophilopoiesis and, therefore, eosinophils. This strain is likely to be used by investigators to elaborate the normal vs pathogenic roles of eosinophils in health and disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908440     DOI: 10.1182/blood-2013-06-508507

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

2.  Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.

Authors:  Milica M Grozdanovic; Christine B Doyle; Li Liu; Brian T Maybruck; Mark A Kwatia; Nethaji Thiyagarajan; K Ravi Acharya; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2020-01-23       Impact factor: 10.793

Review 3.  Novel targeted therapies for eosinophil-associated diseases and allergy.

Authors:  Susanne Radonjic-Hoesli; Peter Valent; Amy D Klion; Michael E Wechsler; Hans-Uwe Simon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-17       Impact factor: 13.820

4.  Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors.

Authors:  Daniela Schuster; Martina Zederbauer; Thierry Langer; Andreas Kubin; Paul G Furtmüller
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.